Singapore markets open in 5 hours 14 minutes

Hercules Capital, Inc. (HTGC)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
19.11-0.19 (-1.01%)
As of 03:46PM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close19.31
Open19.37
Bid19.11 x 1300
Ask19.12 x 1300
Day's range19.07 - 19.42
52-week range13.11 - 20.01
Volume939,580
Avg. volume1,012,613
Market cap3.1B
Beta (5Y monthly)1.29
PE ratio (TTM)8.69
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yield1.92 (9.94%)
Ex-dividend date13 May 2024
1y target estN/A
  • PR Newswire

    Harness Raises $150 Million in New Financing

    Harness, the Modern Software Delivery Platform® company, today announced $150 million in financing from Silicon Valley Bank (SVB), a division of First Citizens Bank, and Hercules Capital, Inc. (NYSE: HTGC). The investment will be used strategically to support the expansion of the Harness platform, including the addition of new modules, further integrating generative AI into the platform, and additional investments in the company's go-to-market engine.

  • Business Wire

    Hercules Capital Announces Date of 2024 Annual Meeting of Stockholders

    SAN MATEO, Calif., May 13, 2024--Hercules Capital, Inc. (NYSE: HTGC) ("Hercules" or the "Company"), will conduct its 2024 Annual Meeting of Stockholders by virtual meeting on Thursday, June 20, 2024 at 9:00 a.m. (Pacific Time). The proxy statement for the meeting was filed on April 23, 2024 and mailed to stockholders of record as of April 19, 2024.

  • GlobeNewswire

    Verona Pharma Announces $650 Million Strategic Financing with Oaktree and OMERS

    Non-dilutive funding will support planned US commercial launch and expansion of ensifentrine’s clinical activities Cash runway extended beyond 2026 LONDON and RALEIGH, N.C., May 09, 2024 (GLOBE NEWSWIRE) -- Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma”), announces it and its wholly-owned subsidiary, Verona Pharma, Inc. (“VPI” and together with Verona Pharma, the “Company”), have entered into strategic financing agreements providing access to up to $650 million from funds managed by Oaktree C